The landscape of U.S. public health in 2025 is witnessing renewed attention as outbreaks of measles and the rising prevalence of Chagas disease underscore vulnerabilities in infectious disease management. Amid these challenges, the ivermectin debate measles Chagas outbreak U.S. has resurfaced nationwide, influencing healthcare policies, community awareness, and...

The intersection of Big Tech and healthcare is rapidly reshaping patient monitoring in the United States. From smartwatches to integrated health apps, technology companies are expanding their influence into medical tracking, generating both excitement and scrutiny. Amid these developments, ivermectin legality in U.S. tracking systems has reappeared in discussions as platforms track...

In 2025, the Centers for Disease Control and Prevention (CDC) faces unprecedented scrutiny. Once regarded as the cornerstone of American public health, the agency now struggles with declining public trust, internal workforce challenges, and increasing political interference. Simultaneously, ivermectin has re-emerged as a divisive topic in U.S. healthcare, sparking debates...